CDKN1B and ovarian carcinoma: In human epithelial ovarian cancer (EOC), exosomal miR-221−3p derived from M2 macrophages promotes cancer growth by reducing the cyclin-dependent kinase inhibitor 1B (CDKN1B) (57).